Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

On 14 November, NDCN's Autoimmune Neurology Group held an event for patients and public, to discuss the research on autoimmune encephalitis at the University of Oxford.

What is autoimmune encephalitis?

Autoimmune encephalitis is an illness affecting the brain. It can cause changes in thought, perception, and memory; seizures; and abnormal movements. In autoimmune encaphalitis, the immune system, which usually prevents infection, malfunctions. It turns against the brain via molecules called antibodies. 

The Oxford Autoimmune Neurology Group led by Sarosh Irani and Paddy Waters studies the cells which produce the antibodies, to work out which medications can destroy these cells and help reduce antibody levels.

What happened on the day?

The research team demystified what goes on in their lab, using a fun and interactive 'Ready Steady Assay!' demonstration based on a popular TV programme (see video below). Patients offered perspectives on their experiences of the condition, as well as what it is like to be involved in research. A representative from the Encephalitis Society explained the role of the charity, and there was an open forum on the future directions research in Oxford could take.

Huge thanks also for an amazingly informative and engaging day yesterday. It gave us all a much deeper understanding.
- Event attendee

How did it go?

All survey respondents strongly agreed or agreed that the event improved their knowledge about autoimmune encephalitis research in Oxford. They all said they would attend another similar event. Comments revealed that the most memorable part of the day was meeting other people affected by encephalitis, and hearing about the cutting-edge research going on here in Oxford.

Similar stories

Two neurologists awarded MRC Senior Clinical Fellowships

Clinical Neurology Research

Two of our Associate Professors, Sarosh Irani and George Tofaris, have been awarded MRC Senior Clinical Fellowships.

Developing diagnostics for COVID-19

Clinical Neurology Coronavirus Research

Associate Professor Sarosh Irani, who heads up our Autoimmune Neurology Group, has been funded by Mologic to help develop diagnostics for COVID-19.

COVID-19 and Guillain-Barré syndrome

Clinical Neurology Coronavirus Research

Multiple recent case reports have suggested a link between COVID-19 and Guillain-Barré syndrome (GBS), an acute, disabling, immune-mediated disorder of the peripheral nervous system. It is currently unclear whether this simply represents a chance association.

Viruses shown to evolve as a result of different immune responses in different ethnic populations

Clinical Neurology Coronavirus Research

New research into the HIV-1 virus has shed light on an important factor in the evolution of viruses, which is likely also to affect SARS-CoV-2 (the virus which causes COVID-19). This new insight could have important implications for vaccine development.

Emerging Leaders Prize celebrates outstanding pain researchers

Award Clinical Neurology

2020’s Emerging Leaders Prize awards £200,000 to outstanding scientists from the University of Oxford, University College London and King’s College London, who are all working in the field of pain research.

Our researchers take part in Oxford Science and Ideas Festival

Public engagement

IF Oxford returns as a digital science and ideas Festival with 100 online events in October. There’s something for everyone, with activities for young children and families, or sessions for teenagers and adults to enjoy alone or as a group from the safety and comfort of home.